For those with metastatic R‐NENs, systemic treatments used for other neuroendocrine tumours such as peptide‐receptor radio nucleotide therapy, tyrosine kinase inhibitors, somatostatin analogues and chemotherapy are often considered.16, 17. Here, SST is linked to neuroendocrine neoplasm.